Status:
COMPLETED
A Clinical Trial Comparing the Efficacy and Safety of Exubera® and Lantus®
Lead Sponsor:
Pfizer
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
30+ years
Phase:
PHASE4
Brief Summary
To compare efficacy and safety of Exubera® vs Lantus® in patients with type 2 diabetes mellitus.
Eligibility Criteria
Inclusion
- Diabetes Mellitus, Type 2 on oral agents
- Age \> 30 years
Exclusion
- Severe Asthma, severe Chronic Obstructive Pulmonary Disease
- Smoking
Key Trial Info
Start Date :
December 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2008
Estimated Enrollment :
261 Patients enrolled
Trial Details
Trial ID
NCT00391027
Start Date
December 1 2006
End Date
August 1 2008
Last Update
July 23 2015
Active Locations (62)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Bornem, Belgium, 2800
2
Pfizer Investigational Site
Brussels, Belgium, 1070
3
Pfizer Investigational Site
Genk, Belgium, 3600
4
Pfizer Investigational Site
Liège, Belgium, 4000